Preparing for Transition from Life Sciences PE to Long/Short Hedge Fund

Hey all,

I’m currently a 2nd-year associate on a life sciences royalty team in private equity. I have a science undergraduate degree, followed by an MBA and CFA. I've done a few years in banking, both full-time and through internships, and I'm quite confident with my modeling skills.

Right now, I do enjoy my role, especially attending healthcare conferences and doing scientific and financial due diligence. My focus is mainly on commercialized assets and a few pre-approval projects, with analysis often taking several weeks. However, I'm looking for something new and more fast-paced with higher earning potential, so I'm considering transitioning to a life sciences long/short hedge fund. I understand the risks involved but am excited about the challenge. I've had conversations with a few recruiters and members of these firms and they always probe my interest in a transition to their L/S firm but I want to make sure I'm prepared since I know just because I've done well in the royalty side doesn't mean the L/S side will be the same

I know hedge funds require more rapid idea generation and analysis for every meeting, which is quite different from the more extended analysis cycle I'm used to.

Questions:

  1. How can I prepare myself over the next year to transition to a long/short investing role?
  2. What type of analysis should I focus on to become a better equities investor?
  3. What should I be reading, and who should I be following to stay updated on market trends and improve my investing skills?
  4. Any specific resources or strategies you recommend for someone coming from a PE background to adapt to the hedge fund environment?

Any advice or insights would be greatly appreciated!

Thanks!

4 Comments
 

All of the questions they have listed are generic to any hedge fund. There are also threads on healthcare/biotech fund/pods too. 
 

 

Voluptatem temporibus ea qui eum. Nobis aperiam natus molestiae ut. Ea aut ipsum ut qui labore.

Career Advancement Opportunities

June 2026 Hedge Fund

  • Point72 99.0%
  • D.E. Shaw 98.1%
  • Citadel Investment Group 97.1%
  • AQR Capital Management 96.2%
  • Magnetar Capital 95.2%

Overall Employee Satisfaction

June 2026 Hedge Fund

  • Magnetar Capital 99.0%
  • Millennium Partners 98.1%
  • D.E. Shaw 97.1%
  • Blackstone Group 96.1%
  • Citadel Investment Group 95.1%

Professional Growth Opportunities

June 2026 Hedge Fund

  • AQR Capital Management 99.1%
  • Point72 98.1%
  • D.E. Shaw 97.2%
  • Citadel Investment Group 96.2%
  • Magnetar Capital 95.3%

Total Avg Compensation

June 2026 Hedge Fund

  • Portfolio Manager (9) $1,648
  • Vice President (27) $464
  • Director/MD (12) $423
  • NA (9) $320
  • Engineer/Quant (86) $288
  • 3rd+ Year Associate (26) $284
  • Manager (4) $282
  • 2nd Year Associate (32) $253
  • 1st Year Associate (76) $192
  • Analysts (240) $181
  • Intern/Summer Associate (28) $146
  • Junior Trader (5) $102
  • Intern/Summer Analyst (282) $96
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”